HLA-DP positive T cells in patients with polymyositis/dermatomyositis

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Polymyositis and dermatomyositis are inflammatory myopathies characterized by immune system attacks on muscles.
• T cells play a crucial role in autoimmune diseases, but specific T cell subsets involved in these conditions require further investigation.
• Human leukocyte antigen (HLA) molecules are critical for T cell recognition and immune responses.

Purpose of the Study:

• To investigate the prevalence and characteristics of HLA-DP+ T cells in patients with polymyositis/dermatomyositis.
• To explore the correlation between HLA-DP+ T cells and clinical parameters, including myogenic enzyme levels and pneumonitis.
• To determine the T cell subsets expressing HLA-DP.

Main Methods:

• Flow cytometry was used to analyze T cell populations in 21 patients with polymyositis/dermatomyositis.
• Quantification of HLA-DP+, HLA-DQ+, and HLA-DR+ T cells, including CD4+ and CD8+ subsets.
• Comparison of T cell proportions with myogenic enzyme levels and assessment of changes after therapy.

Main Results:

• Marked increases in HLA-DP+ T cells (28.5%) were observed compared to HLA-DQ+ and HLA-DR+ T cells.
• HLA-DP was expressed on both CD4+ and CD8+ T cells, with the majority of HLA-DP+ CD8+ cells identified as cytotoxic T cells.
• A significant elevation in HLA-DP+ CD8+ cells was found in patients with active pneumonitis.

Conclusions:

• Elevated levels of HLA-DP+ T cells, particularly cytotoxic CD8+ T cells, are characteristic of polymyositis/dermatomyositis.
• The proportion of HLA-DP+ T cells may serve as a potential biomarker for active pneumonitis in these patients.
• While not directly correlated with myogenic enzyme levels, a decrease in HLA-DP+ T cells post-therapy suggests a role in disease activity.